What does CUSIP 92686J106 represent in this 13F holders report?

CUSIP 92686J106 is the security identifier for VKTX - Viking Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VKTX - Viking Therapeutics, Inc. - Common Stock in Q4 2022?

126 institutional investors reported VKTX - Viking Therapeutics, Inc. - Common Stock for Q4 2022. Use the holders table for investor-level position and value details.

Viking Therapeutics, Inc. - Common Stock (VKTX)

CUSIP: 92686J106

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common Stock
Shares outstanding: 115,694,154
Total 13F shares: 34,003,932
Share change: +7,207,844
Total reported value: $319,613,212
Put/Call ratio: 20%
Price per share: $9.40
Number of holders: 126
Value change: +$76,425,883
Number of buys: 69
Number of sells: 45

Quarterly Holders Quick Answers

What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 92686J106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	2.9%	3,331,089	$9,060,000	—	30 Sep 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	2.7%	3,103,031	$8,440,000	—	30 Sep 2022	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	2.3%	2,673,564	$7,272,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	1.3%	1,466,256	$3,987,000	—	30 Sep 2022	13F
MARSHALL WACE, LLP	13F	Company	1.2%	1,337,380	$3,638,000	—	30 Sep 2022	13F
Laurion Capital Management LP	13F	Company	1.1%	1,299,000	$3,533,000	—	30 Sep 2022	13F
Walleye Capital LLC	13F	Company	0.95%	1,098,330	$2,987,000	—	30 Sep 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.9%	1,046,400	$2,846,000	—	30 Sep 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.85%	986,323	$2,683,000	—	30 Sep 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.79%	913,963	$2,486,000	—	30 Sep 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.78%	906,628	$2,466,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.56%	653,037	$1,776,000	—	30 Sep 2022	13F
DAFNA Capital Management LLC	13F	Company	0.48%	552,400	$1,503,000	—	30 Sep 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.42%	487,313	$1,325,000	—	30 Sep 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.41%	474,239	$1,290,000	—	30 Sep 2022	13F
Ikarian Capital, LLC	13F	Company	0.4%	463,156	$1,260,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	0.35%	399,241	$1,086,000	—	30 Sep 2022	13F
MACQUARIE GROUP LTD	13F	Company	0.29%	330,100	$898,000	—	30 Sep 2022	13F
David M. Knott Jr.	13F	Individual	0.26%	301,803	$821,000	—	30 Sep 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.25%	290,272	$790,000	—	30 Sep 2022	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.22%	259,887	$707,000	—	30 Sep 2022	13F
Affinity Asset Advisors, LLC	13F	Company	0.22%	250,000	$680,000	—	30 Sep 2022	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.21%	247,000	$672,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	0.21%	246,842	$671,000	—	30 Sep 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.21%	240,667	$655,000	—	30 Sep 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.19%	221,483	$602,000	—	30 Sep 2022	13F
CAXTON ASSOCIATES LP	13F	Company	0.17%	201,033	$547,000	—	30 Sep 2022	13F
Ergoteles LLC	13F	Company	0.17%	198,164	$539,000	—	30 Sep 2022	13F
Man Group plc	13F	Company	0.16%	182,683	$497,000	—	30 Sep 2022	13F
GROUP ONE TRADING LLC	13F	Company	0.13%	147,616	$402,000	—	30 Sep 2022	13F
OSAIC HOLDINGS, INC.	13F	Company	0.13%	146,214	$399,000	—	30 Sep 2022	13F
Cornerstone Capital, Inc.	13F	Company	0.12%	143,980	$392,000	—	30 Sep 2022	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.12%	143,207	$390,000	—	30 Sep 2022	13F
J. Goldman & Co LP	13F	Company	0.12%	135,000	$367,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	0.11%	126,796	$345,000	—	30 Sep 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.1%	117,768	$320,000	—	30 Sep 2022	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.1%	113,788	$310,000	—	30 Sep 2022	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.09%	104,728	$285,000	—	30 Sep 2022	13F
Bank of New York Mellon Corp	13F	Company	0.09%	104,144	$284,000	—	30 Sep 2022	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.07%	78,220	$213,000	—	30 Sep 2022	13F
Quantum Private Wealth, LLC	13F	Company	0.05%	62,548	$170,000	—	30 Sep 2022	13F
Jump Financial, LLC	13F	Company	0.05%	60,000	$163,000	—	30 Sep 2022	13F
Fiera Capital Corp	13F	Company	0.05%	52,654	$143,000	—	30 Sep 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.05%	52,247	$143,000	—	30 Sep 2022	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.04%	49,345	$134,000	—	30 Sep 2022	13F
Summit Financial Wealth Advisors, LLC	13F	Company	0.03%	32,524	$131,000	—	30 Sep 2022	13F
PDT Partners, LLC	13F	Company	0.04%	46,758	$127,000	—	30 Sep 2022	13F
Qube Research & Technologies Ltd	13F	Company	0.04%	46,186	$126,000	—	30 Sep 2022	13F
UBS Group AG	13F	Company	0.04%	41,067	$112,000	—	30 Sep 2022	13F
LPL Financial LLC	13F	Company	0.03%	39,619	$108,000	—	30 Sep 2022	13F

Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q4 2022

As of 31 Dec 2022, Viking Therapeutics, Inc. - Common Stock (VKTX) was held by 126 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,003,932 shares. The largest 10 holders included MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Boxer Capital, LLC, BlackRock Inc., Laurion Capital Management LP, GREAT POINT PARTNERS LLC, TWO SIGMA INVESTMENTS, LP, Point72 Asset Management, L.P., D. E. Shaw & Co., Inc., and RENAISSANCE TECHNOLOGIES LLC. This page lists 126 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

126

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.